| 摘要 |
Disclosed is a pharmaceutical composition for treating glaucoma and ischemic retinopathy in a mammal, comprising a pharmaceutically acceptable diluent and a therapeutically effective amount of a compound of the formula: (see above formula) (wherein Ar is an aryl such as benzoisothiazolyl; n is 1 or 2; and X and Y together with the benzene ring to which they are attached, form a fused cyclic ring system such as optionally substituted oxindole) or a pharmaceutically acceptable acid addition salt thereof.
|
